Introduction
Benign thyroid nodules are common in the general population especially in iodine-deficient areas. The use of ultrasound (US) in clinical practice has increased the majority of asymptomatic, benign thyroid nodules which are stable in size and can be monitored with clinical and US examinations [1] . Considering that in large thyroid nodules no effective medical therapies have been identified to reduce their size, surgery, which still represents the common treatment in cold thyroid nodules, may cause local symptoms and patient concern. Recently, minimally invasive techniques have been proposed for treating large benign thyroid nodules. Percutaneous ethanol injections are now acknowledged as a rapid, effective, and inexpensive treatment for cystic thyroid lesions [2] whereas thermal ablation with laser or radiofrequency is used more frequently in solid or complex nodules [3] . Other techniques such as cryoablation, highfocused ultrasound, microwaves, and electroporation are not recommended in clinical practice [4] . Over the last few years, several studies [5] [6] [7] [8] [9] [10] [11] have demonstrated that percutaneous laser ablation under ultrasound guidance is able to reach a target lesion within the thyroid with great precision. Laser treatment is quick (5-20 minutes) and destroys thyroid tissue in a predictable, repeatable way without any major complications when performed by experienced operators. However, the success of the treatment depends on its monitoring in order to evaluate tissue damage, the margins of the necrotic areas, and the evolution of the results during follow-up. Several studies [12] [13] have shown that laser treatment is more effective than L-T4 treatment in reducing the nodular volume and related compressive symptoms; therefore, the method seems to be a promising procedure. Conventional US provides information on ultrasound patterns correlated with thyroid pathologies [11, [14] [15] [16] , but the sensitivity, specificity, and accuracy are extremely variable from study to study. As reported in the consensus on thyroid nodules, a firm or hard consistency at palpation is associated with an increased risk of malignancy. However, this clinical parameter is highly subjective and depends on the examiner's experience.
Elastography is a newly developed dynamic technique that uses US to give an estimation of tissue stiffness. In addition, US can be used to obtain information on the composition of the nodular tissue by using spectral analysis of the radiofrequency signal (RF) which contains information about ultrasound-tissue interactions [16] [17] [18] [19] . Through the identification of new coefficients [20] [21] [22] [23] [24] [25] [26] , the spectral analysis of the RF signal is able to provide information regarding the biological structure of the tissue. The use of RF could therefore be an interesting support for conventional US as it provides information about the condition of the tissue and the modifications occurring during and after laser ablation, which can thus be use dto establish its effectiveness.
The proposed investigation method for spectral analysis called HyperSPACE (Hyper SPectral Analysis for Characterization in Echography) [27] [28] [29] [30] implements a sub-band decomposition of the local signal spectrum and operates in hyperspectral domain. Important results of this method were obtained from an experiment involving ten Italian hospital clinics conducted to differentiate the two most common breast pathologies [27] [28] [29] [30] .
In this research, HyperSPACE was applied to characterize the structure of benign nodular thyroid tissue before laser treatment and the results obtained were compared with those of conventional US and elastography and correlated with the extension of the necrosis area induced by laser ablation.
Materials and methods

Investigation Method
The method is based on the spectral analysis of the RF ultrasonic signal and consists of several steps fully described in previous published papers [27] [28] [29] [30] .
In the first step, the RF signal is filtered by means of a bank of N filters, performing an N sub-bands decomposition of the spectral band. In the second step, the coefficients obtained from the decomposition are analyzed and processed in N dimensional spectral hyperspace in order to generate the HyperSPACE coefficients (hs) [30] that are subjected to a training phase. In the training phase, the hs coefficients, belonging to selected Regions of Interest (ROIs) on the B-mode image, are trained to identify sets of spectral parameters, called Configurations, able to characterize the investigated ROIs. In particular, during this phase, the physician selects the area of the thyroid nodule on the B-mode, which is automatically subdivided into three different ROIs by the algorithm as shown on the left of fig1a. On the right of the same figure, the hs distributions of red, green, and blue ROIs, are represented in a three-dimensional projection of hyperspace and it is interesting to note that the coefficients have different shapes and positions for each ROI in the hyperspace considered. In the fourth step, called Classification, the algorithm detects the presence of the previously defined Configurations over the entire RF image. By processing hs coefficients [30] , several clusters relating to each ROI are obtained (fig 1b) and the hyper volume that contains the combination of all clusters, relating to each ROI, is called Configuration (fig 1c) .
During the Classification phase, Configurations detected over the entire image are visualized on the Bmode image by superimposing a color code associated with each Configuration, obtaining the HyperSPACE image. Therefore, if, for example, three Configurations are present in a RF image, the final B-mode will have three- The Pilot Study The Hyper-SPACE was applied on data acquired at the Endocrinology 1 Department of the University Hospital of Pisa (Italy) [31] [32] [33] [34] [35] . In this study, all patients undergoing clinical investigation signed an informed consent form that allowed them to participate. The Ethics Committee approved the clinical protocol, which defined the inclusion and exclusion criteria for enrolling patients, the characteristics of the acquisition procedure, the diagnostic tests to be performed on the patients, and the type of data to be collected. The inclusion criteria established that all patients had to be 20 years of age or older, with the presence of a single or dominant nodule, well defined both clinically and with ultrasound. The nodular volume was 8-24 ml (maximum diameter of 3-5 cm). At the scintiscan, the nodule had to be cold. All patients were euthyroid with undetectable serum calcitonin and all nodules were benign at cytology (Thyr 2).
The set up used for the acquisition of RF echographic signal consisted of the ultrasound equipment Mylab 70 (Esaote S.p.A, Florence, Italy), optically connected to a FEMMINA [36] a versatile system that makes it possible to acquire and process the RF signal in real time. The probe used was the linear array LA435 (Esaote S.p.A, Florence, Italy) with a nominal frequency of 10 MHz. The instrumental acquisition parameters were: excitation frequency 12.5 MHz, Power 80% of dynamic, TGC 50% of dynamic, at every depth, total gain 65% of dynamic, and focus depth on nodule.
Conventional US was performed before laser treatment. During the US examination, 20 RF frames were acquired for each nodule section (sagittal and transversal) from each patient. Laser Ablation Therapy (LAT) was carried out in a single session by inserting two 21-gauge spinal needles into the target thyroid lesion under US monitoring. The ablation was performed with a 1064-nm neodymium yttrium-aluminum garnet (Nd-YAG) laser (Echolaser; Elesta, Italy) with an output power of 3 W. Energy delivery was 3600 J for nodules 6-13 mL and 7200 J for nodules measuring 14-17 ml. With US monitoring, the area under treatment was visualized as a hyperechoic zone that gradually enlarged due to the formation of gas micro-bubbles in the coagulated tissue. After an interval of 2-3 hours following laser treatment, the patient was examined again with the echographic equipment and additional RF frames of nodules were acquired as per the previous procedure. In this work, in order to characterize the nodular tissue before treatment, 1200 RF frames deriving from 30 patients were processed. The data set of enrolled patients was composed of 25 females and 5 males aged between 37 and 81 years [mean age±standard deviation (SD) 53±12].The training set consisted of 24 RF frames relating to 8 patients, randomly selected from transversal and sagittal sections. All the other frames were used in the classification. In this study, only three Configurations represented by means of the colors Red (R), Green (G) and Blue (B) were chosen to be developed. Moreover, by calculating the coverage percentage of each color in respect of nodular volume and the reciprocal ratios of these percentages in the HyperSPACE images, the nodules were divided into three different groups (A, B, and C), defined by means of the clustering algorithm k-means [37] . After that, every nodule belonging to each group was correlated to the percentage of necrosis extension, in order to correlate the results with the damage inflicted by laser ablation.
Results
The RF images related to the 30 patients, described above, were processed through the algorithm and, for each patient, the percentages of colored areas in the HyperSPACE images before ablation was estimated obtaining the distribution reported in the histogram of fig 3. The three groups, wherein the nodules were subdivided, exhibit mean values of the colors coverage that are different from each other, as reported in figure 4 and in Table I .
Examples of HyperSPACE images for each group are represented in fig 5 .
In order to verify if different colors distributions and, accordingly, if different tissue features of nodules were related to different responses to laser treatment, the ratios between necrosis volume (VNEC) and nodule volume (VNOD) were calculated for all nodules obtaining the histogram shown in fig 6, where values are represented taking into account the group to which they belong. For each group the mean value, standard deviation and median were estimated, as reported in Table II . The extensions of necrosis were estimated by measuring the nonperfused area in the B-mode image of the ablated nodule after injection of the contrast agent.
Moreover, a comparison of HyperSPACE and elastosonography images was performed with the aim to put in evidence the different information coming from one or the other. In fig 7 it can be observed that all three nodules have similar elastosonography images, (their score is equal to one in each case). On the other hand, their HyperSPACE images are different and each nodule belongs to a different group with a different range of necrosis extension. In addition, areas with the same echographic appearance in traditional B-mode are characterized by different Configurations.
Discussions
Percutaneous laser ablation is considered a minimally invasive surgical technique that offers numerous benefits for the patient and excellent results in reducing thyroid nodules. The effectiveness of this type of technique may be increased by using a monitoring system capable of evaluating not only the damage induced in the tissue during treatment, but also the results that can be evaluated during follow-up of patients. Moreover, a method that provides information about the nodule composition, or- ganization and structural characteristics, may orient the kind of therapeutic treatment. Ultrasound, which seems to be a valid support for monitoring laser treatment, is currently used to diagnose nodules and guide the insertion of needles into the thyroid during treatment with conventional B-mode images. New techniques process ultrasonic signals in order to extract further information from the tissue. Elastosonography provides an estimation of tissue stiffness, which seems to be correlated to the pathological condition of the nodule [31] [32] [33] [34] [35] . The proposed HyperSPACE algorithm is based on the spectral analysis of the radiofrequency signal that is analyzed in an N dimensional frequency domain. In this preliminary study, the method was aimed to assess how sets of spectral parameters, called Configuration, occur among benign nodules in different patients and how they change before and after treatment in the same nodule. The interesting clinical relevance, arising from this experimentation, seems to be the correlation between the distributions of Configurations (represented by colors on the B-mode) and extension of necrosis areas induced by laser ablation. The necrosis extension is not accepted as a biunique reliable indicator of the volume nodule reduction in the follow up; however, this result may be important in the perspective of correlating the characteristics identified by HyperSPACE analysis to the response of laser ablation. Indeed, it may identify parameters that foresee the success of laser treatment and may orient the setting of the laser parameters, such as power, energy and duration for a more effective treatment.
The study has highlighted that nodules exhibit different Configurations (colors) distributions that could be indicative of the response of nodular tissue to the laser treatment. This observation may be interpreted as the prevalence of one Configuration (color) in respect of the other or a particular combination of Configurations may be indicative, a priori, of damage that could be induced by laser treatment. In particular, in this pilot study, we have noticed that the prevalence of blue Configuration corresponds to a major necrosis extension; however, a more extensive experiment on a large database is necessary to confirm that.
Moreover, by comparing the HyperSPACE images with those of elastosonography, referring to the same nodules, it can be observed that nodules classified with the same elastographic score or the same echographic appearance have a different Configuration distribution which allowed a classification of nodules into three groups that exhibit different ranges of necrosis extension.
Therefore, HyperSPACE, compared to conventional echographic images and elastosonography seems to provide different and more extensive information about nod- The resolution of the characterization of the nodule can be effectively incremented by increasing the number of Configurations, as long as they still offer an easy reading of the images supporting the diagnosis. HyperSPACE images exhibit a high selectivity in detecting nodular areas; instead the elasonography images show colored areas both inside and outside the nodule, making image interpretation and stiffness score evaluation of the nodule more difficult. HyperSPACE was also applied to the nodules 2-3 hours after laser treatment, by using the same Configurations set for characterizing the non-treated nodules. The treated nodules exhibited different distributions of Configurations or the disappearance of some Configurations with respect to the same before ablation and this may mean that the tissue modified its spectral parameters due to damage induced by the laser (data not shown). As said above, in the future, a larger number of patients will be necessary to correlate the Configurations or combinations of them with the success of laser treatment by evaluating not only the necrosis area, but, primarily, the reduction of nodular volume in the follow up of patients.
Conclusion
The HyperSPACE algorithm could be a valid support to assess the effectiveness of laser ablation and define the nodule characteristics for indicating a priori the success of the treatment but the preliminary results have to be confirmed in a much more extensive study.
